Adiponectin promotes syncytialisation of BeWo cell line and primary trophoblast cells
- 4.7k Downloads
In human pregnancy, a correct placentation depends on trophoblast proliferation, differentiation, migration and invasion. These processes are highly regulated by placental hormones, growth factors and cytokines. Recently, we have shown that adiponectin, an adipokine, has anti-proliferative effects on trophoblastic cells. Here, we complete this study by demonstrating that adiponectin modulates BeWo and human villous cytotrophoblast cell differentiation.
We showed that hCG secretion was up-regulated by adiponectin treatment in both BeWo cells and human cytotrophoblasts from very early placentas (5-6 weeks). The expression of two trophoblast differentiation markers, leptin and syncytin 2, was also up-regulated by adiponectin in BeWo cells. Moreover, adiponectin treatment induced a loss of E-cadherin staining in these cells. In parallel, we demonstrated that AdipoR1 and AdipoR2 are up-regulated during forskolin induced BeWo cell differentiation, reinforcing the role of adiponectin in trophoblast syncytialization. SiRNA mediated down-regulation of AdipoR1 and AdipoR2 was used to demonstrate that adiponectin effects on differentiation were essentially mediated by these receptors. Finally, using a specific inhibitor, we demonstrated that the PKA signalling pathway could be one pathway involved in adiponectin effects on trophoblast differentiation.
Adiponectin enhances the differentiation process of trophoblast cells and could thus be involved in functional syncytiotrophoblast formation.
KeywordsTrophoblast Cell BeWo Cell Placental Villus Trophoblast Differentiation Villous Cytotrophoblasts
AMP Activated Protein Kinase
Protein Kinase A
Mitogen Activated Protein Kinase
cyclic Adenosine Mono Phosphate
Reverse Transcription-Polymerase Chain Reaction
In human pregnancy, trophoblast cells play an essential role in embryo implantation and placental development. These cells differentiate according to one of two distinct pathways. In the extravillous pathway, cytotrophoblasts (CT) proliferate, differentiate into an invasive phenotype, and penetrate into the maternal decidua and myometrium [1, 2]. In the villous pathway, mononuclear CT fuse to form a specialized multinuclear syncytium called syncytiotrophoblast (ST) on the outer layer of placental villi . ST formation plays an important role in human placentation. This process might be affected in some pathological pregnancy situations. For example, altered ST formation was observed in human preeclampsia .
The ST layer is the site of many placental functions necessary for foetal growth and development, including nutrient, gas exchanges, and synthesis of steroid and peptide hormones . Characteristics related to trophoblast differentiation include the production of hormones like human chorionic gonadotropin (hCG), human placental lactogen, and leptin . However, morphological changes, which involve fusion of CT to form the ST layer represent a hallmark of this differentiation. Studies have highlighted the impact of adhesion molecules such as cadherins in trophoblast differentiation. Among these, E-cadherin is localized at the membrane of the isolated CT and disappears when the CT fuse into ST [4, 5]. Very recently, studies have demonstrated the role of former envelope viral proteins derived from human endogenous retrovirus (HERVs) in trophoblast cell fusion, of which syncytin-1  and syncytin-2  seem to be of high importance. Moreover, syncytin-2 mRNA and protein are particularly expressed in the ST [7, 8].
Different in vitro studies have shown that the villous CT differentiation could be modulated by hormones and by soluble factors. For example, epidermal growth factor (EGF) , 17β-estradiol , granulocyte macrophage-colony stimulating factor (GM-CSF) , glucocorticoids , and hCG  induce differentiation, whereas tumor necrosis factor α (TNFα) [2, 14] and tumor growth factor β1 (TGFβ1)  impair this process. Adipokines such as leptin and adiponectin have recently been shown to affect the reproductive system through central effects on the hypothalamus and/or peripheral effects on the ovary, endometrium, or directly on the embryo and placenta developments [16, 17, 18, 19, 20, 21]. Indeed, leptin is specifically expressed in the ST , and is considered as a new placental hormone [18, 22]. Adiponectin is a cytokine, predominantly produced by adipose tissue, and present at high concentrations in human circulation (5-15 μg/ml) . This adipokine is described as an insulin sensitizing hormone [24, 25, 26], and has been shown to have anti-inflammatory, anti-angiogenic, anti-atherosclerotic and anti-proliferative roles in various cell types . Adiponectin is a 30 kDa protein that is assembled into an array of complexes composed of adiponectin multimers. Adiponectin subunits assemble into trimers called low molecular weight complexes (LMW), hewamers or middle molecular weight forms (MMW), or more elaborate high molecular weight complexes (HMW) composed of 9 hewamers. The HMW form is predominant in human circulation . Two specific adiponectin receptors, AdipoR1 and AdipoR2 have been identified . Both receptors contain seven transmembrane domains but are structurally and functionally distinct from G-protein coupled receptors. AdipoR1 and AdipoR2 are both expressed in human endometrium and placenta [19, 29, 30]. However, adiponectin is only produced by endometrial cells at the foetal-maternal interface . An additional receptor for adiponectin, T-cadherin, has recently been described  but is not expressed in human trophoblast . AdipoR1 and AdipoR2 activate different signal transduction pathways such as the AMPK, PKA, PI3K and P38/P42/P44 MAPK pathways [16, 25, 28, 32]. Recently, we have shown that adiponectin exerts anti-proliferative effects on trophoblastic cell lines (JEG-3 and BeWo) and also on human trophoblasts . Moreover, it has been shown that adiponectin serum concentrations are deregulated in some placental pathologies as gestational diabetes mellitus , and preeclampsia [34, 35]. However, to date, there are no data concerning the direct impact of adiponectin in trophoblast differentiation.
To study adiponectin effects on trophoblast differentiation, the widely used trophoblast differentiation model BeWo choriocarcinoma cell line was chosen [36, 37]. These cells have indeed a high degree of similarity to normal placental trophoblasts and can morphologically and functionally differentiate in vitro into ST. In particular, BeWo differentiation can be strongly induced by cAMP analogs or forskolin, an adenylate cyclase activator [37, 38]. Thus, the effects of adiponectin on differentiation in both BeWo cells and in villous cytotrophoblasts were tested by measuring hCG secretion and expression of various differentiation markers (leptin, syncytin-2 and E-cadherin) to evaluate the associated morphological and biochemical changes.
The culture medium DMEM/F12, penicillin, streptomycin, forskolin, Compound C, H89, and bovine serum albumine (BSA) were purchased from Sigma Chemical Co. (St Louis, Mo, USA). Fetal Calf Serum (FCS) was purchased from Gibco (Invitrogen, Carlsbad, Ca, USA). Recombinant human adiponectin was provided by R&D Systems Europe Ltd (Abingdon, UK), Superscript II Rnase H- RT by Invitrogen corporation (Carlsbad, Ca, USA), hCG by Organon (Puteaux, France), and RNAguard by Pharmacia Biotechnology (Uppsala, Sweden). Trypsin was provided by Difco Laboratories (Detroit, Mi, USA). The origin of the different antibodies used are described in the following paragraphs.
BeWo cell culture
The human choriocarcinoma cell line BeWo was obtained from American Type Collection of Cell (Manassas, Va, USA). Cells were maintained at 37°C under 5% CO2, 95% air atmosphere in phenol-red free DMEM/F12 medium with 15% FCS, streptomycin (10 μg/ml) and penicillin (100 U/ml). On the day following plating, BeWo cells were cultured in DMEM/F12 medium with 1% FCS in the presence of various agents such as forskolin (50 μM), adiponectin (25 ng/ml or 250 ng/ml or 500 ng/ml), 17β-estradiol (0.1 μM), progesterone (0.1 μM) and H89 (10 μM).
Isolation of villous cytotrophoblasts
This study was approved by the local ethical committee (CCP) and informed consent was obtained from each donor before clinical sampling.
First trimester human placental tissues (5-11 week gestational age) were obtained from healthy pregnant women aged between 16 and 36 when undergoing legal abortions. Human placental villous cells were prepared from tips of placental villi as previously described . Placental villi were incubated in HBSS containing 0.125% trypsin, 4.2 mM MgSO4, 25 mM Hepes, and 50 U/ml Dnase type IV at 37°C without agitation. The first 15 min trypsin digestion containing a mix of extravillous and villous CT was discarded. The chorionic villi were then incubated in the same trypsin solution for 15 min at 37°C (three times) and finally washed four times with warm HBSS. Each time, the supernatant containing villous CT was collected after tissue sedimentation, filtered through 100 μm nylon screen, and centrifuged at 200 g for 10 min. Cells were washed twice and then filtered through 40 μm nylon screen. The cell supension was layered over a discontinuous Percoll gradient and centrifuged for 25 min at 1000 g. The layer corresponding to 40-45% percoll containing villous CT was washed twice in DMEM/F12 medium supplemented with 10% FCS. Cells were seeded in 24 well culture plates containing DMEM/F12 medium with 10% FCS, streptomycin (100 μg/ml), penicillin (100 U/ml), and gentamycin (5 μg/ml). Purified villous CT cultures were characterized by positive staining for cytokeratin 7 (CK7) (95% positive cells) and by the observation of cell aggregates and syncytiotrophoblasts from 48 to 72 h. In vitro, purified mononuclear CT spontaneously differentiate to form a multinucleated syncytium after 3 days in culture .
BeWo cell and villous CT pellets were resuspended in a PBS buffer. DNA content was quantified using an InstaGene Matrix Reagent (Biorad, Hercules, Ca, USA) according to the manufacturer's instructions.
hCG and cAMP secretions
BeWo cells and villous CT were cultured in DMEM/F12 medium supplemented with 1% FCS with or without adiponectin (250 ng/ml) or forskolin (50 μM) during 24, 48, and 72 h. The culture media were changed every 24 h. The hCG concentrations were measured in the culture medium using an automated immuno-chemiluminescence analyser Architect (Abbott, Rungis, France). In order to compare the secretion of hCG in supernatants, results were normalized to 1 μg of DNA. cAMP concentrations were measured in the culture medium using a cAMP [3H] assay system, code TRK432 (GE healthcare, Orsay, France), according to the manufacturer's instructions.
Primers used for PCR
PCR product (bp)
5' TTC TTC CTC ATG GCT GTG ATG T3'
5'AAG AAG CGC TCA GGA ATT CG 3'
5' ATA GGG CAG ATA GGC TGG TTG A 3'
5' GGA TCC GGG CAG CAT ACA 3'
5' TCG GAT ACC TTC CCT AGT GC 3'
5' GTA TTC CGG AGC TGA GGT TG 3'
5' CCA AGA TGG ACC AGA CAC TG 3'
5' GCC ACC ACC TCT GTG GAG TA 3'
5' TGC ACA GGA GCC AAG AGT GAA 3'
5' CAC ATC ACA GCT CCC CAC CA 3'
5' TGC TGT CTC CAT GTT TGA TGT ATC T 3'
5' TCT CTG CTC CCC ACC TCT AAG T 3'
BeWo cells (4×104 cells/well), or villous CT (2×105 cells/well), were plated in a labtech culture device (BD biosciences, San Jose, Ca, USA) and cultured in DMEM/F12 medium supplemented with 1% FCS with or without adiponectin (250 ng/ml) or forskolin (50 μM). After 24, 48 and 72 h treatment, cells were washed three times in PBS buffer and fixed in methanol for 10 min at 4°C. Non-specific IgG binding was blocked by incubation in PBS with 3% BSA for 1 h. Samples were then incubated with primary monoclonal mouse anti-human E-cadherin antibody (Ref: 610181, BD biosciences; San Jose, Ca, USA) (1:200 dilution in PBS BSA 3%) overnight at 4°C. The slides were then rinsed with PBS buffer and incubated with FITC conjugated goat anti-mouse secondary antibody (Ref: SC-2010, Santa Cruz Biotechnology, Inc; Santa Cruz, CA, USA) (1:200 dilution in PBS BSA 3%) for 1 h at room temperature. Cell nuclei were counterstained with DAPI. Syncytium formation was measured by observing the distribution of E-cadherin and nuclei in cells. Control studies were performed using the above described methods using mouse non-specific serum instead of primary antibody.
RNA interference for AdipoR
Two pairs of small-interfering RNAs (siRNAs) corresponding to different regions of each receptor gene were chemically synthesized by Qiagen (Courtaboeuf, France). The sequences of the sense siRNAs were: for human AdipoR1: AAG GAC AAC GAC TAT CTG CTA and CTG GCT AAA GGA CAA CGA CTA and for human AdipoR2: ACC AAT TTA AGT GAA CAT TTA and CGG CTC TCC TTG AAT AAG AAA. A fluorescently labeled, non-silencing control siRNA was useful for the optimization of transfection conditions and as a control for non-specific silencing effects. For the knockdown experiments, BeWo cells were plated in 24-well dishes at 1×105 cells/well and cultured for 24 h in medium without antibiotics. Cells were transfected with siRNAs (5 nM/well) using a Lipofectamine RNAiMAX transfection reagent from Invitrogen (Carlsbad, CA, USA) according to the manufacturer's instructions. Adiponectin (500 ng/ml) was added 24 h after transfection. After 72 h of culture, the mRNA expression was analyzed as described above.
Statistical analysis was performed using the raw data from 6 to 10 separate experiments. The non-parametric paired Wilcoxon test was applied to compare one adiponectin concentration effect versus the control situation (without adiponectin) for a given time exposure.
Adiponectin effects on biochemical trophoblast differentiation
Effects of adiponectin on hCG production in BeWo cells and human villous CT
In parallel, we investigated adiponectin effects on CT cells purified from very early first-trimester human placentas (5-6 week gestational age) or early first-trimester human placentas (10-11 week gestational age). In villous CT purified from very early placentas, we observed an increase of hCG production in the presence of adiponectin that was only significant at the maximum concentration (500 ng/ml) (Figure 1C). By contrast, in cells purified from later placentas, adiponectin (250 and 500 ng/ml) reduced hCG production (Figure 1D).
Effects of adiponectin on leptin mRNA expression in BeWo cells and human villous CT
It is well established that leptin is produced by ST and can be considered as a marker of biochemical trophoblast differentiation . Accordingly, we investigated the effects of adiponectin on leptin mRNA expression in BeWo cells and CT cells.
As can be seen in Figure 2B, adiponectin at 25 ng/ml and at 250 ng/ml stimulates leptin mRNA expression in CT cells after 48 h exposure (1.73 ± 0.45 and 2.14 ± 0.45 fold change, respectively).
Effects of adiponectin on syncytin-2 mRNA expression in BeWo cells and human villous CT
Adiponectin effects on morphological trophoblast differentiation
Effects of adiponectin on E-cadherin immunostaining in BeWo cells and human villous CT
E-cadherin is a cell adhesion molecule expressed only in isolated CT. During the trophoblast differentiation process, E-cadherin mRNA and protein are down-regulated in association with loss of E-cadherin staining from the surface of fusing cells . Thus, E-cadherin staining is a qualitative marker of trophoblast syncytialization.
E-cadherin staining was also observed in primary villous CT after 48 h exposure to adiponectin. With this time exposure, under control conditions (without adiponectin), we observed that some cells had spontaneously fused and were negative for E-cadherin staining (Figure 4D). Cells exposed to adiponectin for 48 h expressed less E-cadherin than cells cultured in control conditions. Very few cells still expressed E-cadherin (Figure 4E). A negative staining control can be observed on Figure 4F.
Signalling pathways involved in adiponectin effects on trophoblast differentiation
Regulation of AdipoR1 and AdipoR2 mRNA expressions in BeWo cells
Finally, as some studies have described a down-regulation of AdipoR by adiponectin itself [41, 42, 43], we studied AdipoR1 and AdipoR2 mRNA expressions in BeWo cells after 24 h exposure to human recombinant adiponectin. We observed a small but significant decrease of AdipoR2 mRNA expression (0.77 ± 0.04 fold change) in the presence of low adiponectin concentration (25 ng/ml) (Figure 5B). However, a higher adiponectin concentration (250 ng/ml) did not modify AdipoR1 and AdipoR2 mRNA expressions in BeWo cells (Figure 5A-B).
SiRNA down-regulation of AdipoR in BeWo cells
Transduction pathways involved in adiponectin effects on BeWo cells
The classical signal transduction pathway involved in CT differentiation is the activation of the adenylate cyclase -cAMP- PKA pathway . We tested the impact of the PKA pathway on the induction of hCG secretion by adiponectin in BeWo cells using a PKA transduction pathway inhibitor.
Many factors involved in the regulation of trophoblast differentiation have been described. Some of them are also involved in trophoblast proliferation. We have recently shown that adiponectin exerts anti-proliferative effects on trophoblast cells . In the present study, we provide new evidence that adiponectin also promotes a trophoblast differentiation process.
We have examined direct adiponectin effects on BeWo cell and villous CT differentiation by studying biochemical and morphological markers of the ST. We have found that adiponectin was able to i) up-regulate expression of fusion markers as syncytin-2 and ii) reduce E-cadherin membrane staining, indicating that adiponectin promotes the syncytialization of trophoblast cells. Moreover, we have shown for the first time that adiponectin induces a strong increase of leptin expression in BeWo cells and human villous CT. In this way, adiponectin could potentiate the positive effects of leptin on proliferation and invasion of trophoblast cells [21, 22, 45].
In BeWo cells, adiponectin also mediates a modest but reproducible induction of hCG production. To investigate the physiological relevance of this result, we examined the effects of adiponectin on hCG production in villous CT. We observed that adiponectin exerts a gestational age-dependent dual action on first trimester placentas. Like in BeWo cells, we observed an up-regulation of hCG production by adiponectin in villous CT purified from very early placentas (5-6 week gestational age). By contrast, in cells purified from later placentas (10-11 week gestational age), adiponectin decreased hCG production. This last result is in accordance with another study showing a down-regulation of hCG production by adiponectin on the ST of term placentas . Moreover, similar results were observed with the placental growth factor EGF, that has gestationnal age-dependent effects in first trimester placentas . This switch could be related to the oxygen exposure during placentation. Indeed, it is well established that during early pregnancy, placentation occurs in a relative hypoxic environment. After 10-12 weeks' gestation, the intervillous space opens to maternal blood and results in exposure of the trophoblasts to increased oxygen levels . In this context, we can hypothesize that the dual effect of adiponectin on hCG production between 5-6 weeks and 10-11 weeks of gestation could be dependent on signalling pathways and/or transcriptional factors sensitive to oxygen concentrations . Experiments are currently in progress in our laboratory to test this hypothesis.
We have thus shown that adiponectin is a new regulator of leptin and hCG production, which are both essential placental hormones. Moreover, it was recently shown that leptin expression is up-regulated by hCG in the trophoblastic cell line BeWo and in placental explants  and, inversely, that leptin increases hCG production in trophoblast and adipose cells [50, 51, 52]. Adiponectin, through direct or indirect actions, could strengthen this amplification loop between hCG and leptin. Moreover, the positive effect of adiponectin on hCG expression might be reinforced by the up-regulation of AdipoR1 by hCG itself (data not shown) . This last finding is in accordance with an in vivo study showing an up-regulation of AdipoR1 -specifically by hCG- in rat ovaries . Silencing the AdipoR1 and AdipoR2 genes suppressed adiponectin effects on leptin expression. This result suggests a critical impact of AdipoR in adiponectin regulation of trophoblast differentiation.
Biological effects of adiponectin are initiated by AdipoR1 and AdipoR2 inducing the activation of protein kinases, mainly the AMPK but also the PKA pathways . The rise of intracellular cAMP production by the PKA pathway is widely described as the main signal mediating trophoblast differentiation . Thus, we used a specific inhibitor (H89) to investigate the impact of PKA signalling pathway in adiponectin effects in BeWo cells. We show that the addition of H89 suppressed the positive effect of adiponectin on hCG secretion. Moreover, adiponectin increases cAMP release in BeWo cells, reinforcing PKA signalling impact. However, this increase was more pronounced in the presence of forskolin and could explain the difference between adiponectin and forskolin effects on hCG production.
Finally, we found that AdipoR1 and AdipoR2 mRNA expressions were increased by forskolin, suggesting a cAMP dependent mechanism. This up-regulation of the AdipoR could maintain a higher sensitivity to adiponectin in trophoblast cells and thus promote the positive effects of adiponectin on trophoblast differentiation.
A recent study showing that adiponectin induces differentiation and fusion of muscle cells via AMPK pathway . Our results show that adiponectin can promote cell fusion in another cell type.
The process of syncytialization is linked to the early stages of the apoptotic cascade within cytotrophoblast cells . In particular, initiator caspase 8 and caspase 14 are involved in this process [56, 57]. Adiponectin has been described as a pro-apoptotic factor in many cell types, including breast cancer cells  and endometrial cells . Further experiments will be needed to establish whether adiponectin effects on differentiation are also mediated by these caspases.
Inappropriate trophoblast differentiation is a potential cause of the aetiology of pre-eclampsia and fetal growth restriction. Altered plasma adiponectin concentrations have been described in women with pre-eclampsia , reinforcing its possible impact on the control of trophoblast differentiation.
In conclusion, our study reveals a novel function for adiponectin in modulating trophoblast differentiation.
The authors gratefully acknowledge T. Fournier, Ph.D. for his helpful advice in conducting the EVT cell culture assays and the Department of gynaecology and obstetrics, CHI de Poissy-St Germain for their courtesy in making first trimester human placental tissue available.
- 11.Garcia-Lloret MI, Morrish DW, Wegmann TG, Honore L, Turner AR, Guilbert LJ: Demonstration of functional cytokine-placental interactions: CSF-1 and GM-CSF stimulate human cytotrophoblast differentiation and peptide hormone secretion. Exp Cell Res. 1994, 214 (1): 46-54. 10.1006/excr.1994.1232.CrossRefPubMedGoogle Scholar
- 19.Takemura Y, Osuga Y, Yamauchi T, Kobayashi M, Harada M, Hirata T, Morimoto C, Hirota Y, Yoshino O, Koga K, Yano T, Kadowaki T, Taketani Y: Expression of adiponectin receptors and its possible implication in the human endometrium. Endocrinology. 2006, 147 (7): 3203-3210. 10.1210/en.2005-1510.CrossRefPubMedGoogle Scholar
- 28.Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003, 423 (6941): 762-769. 10.1038/nature01705.CrossRefPubMedGoogle Scholar
- 32.Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation. 2000, 102 (11): 1296-1301.CrossRefPubMedGoogle Scholar
- 35.Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V, Cetin I, Cortelazzi R, Beck-Peccoz P, Spada A: Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf). 2007, 66 (3): 447-453. 10.1111/j.1365-2265.2007.02761.x.CrossRefGoogle Scholar
- 39.Handschuh K, Guibourdenche J, Tsatsaris V, Guesnon M, Laurendeau I, Evain-Brion D, Fournier T: Human chorionic gonadotropin expression in human trophoblasts from early placenta: comparative study between villous and extravillous trophoblastic cells. Placenta. 2007, 28 (2-3): 175-184. 10.1016/j.placenta.2006.01.019.CrossRefPubMedGoogle Scholar
- 41.Bauche IB, Ait El Mkadem S, Rezsohazy R, Funahashi T, Maeda N, Miranda LM, Brichard SM: Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice. Biochem Biophys Res Commun. 2006, 345 (4): 1414-1424. 10.1016/j.bbrc.2006.05.033.CrossRefPubMedGoogle Scholar
- 45.Castellucci M, De Matteis R, Meisser A, Cancello R, Monsurro V, Islami D, Sarzani R, Marzioni D, Cinti S, Bischof P: Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. Mol Hum Reprod. 2000, 6 (10): 951-958. 10.1093/molehr/6.10.951.CrossRefPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.